Update on the use of direct oral anticoagulants for the prevention and treatment of thromboembolism

被引：0
|
作者：
Jacobs, Anna [1 ,2 ]
Kabra, Rajesh [3 ]
Das, Pranab [4 ]
Oliphant, Carrie S. [1 ,2 ]
机构：
[1] Methodist Univ Hosp, Dept Pharm, 1265 Union Ave, Memphis, TN 38104 USA
[2] Univ Tennessee, Coll Pharm, Dept Clin Pharm, 920 Madison Ave, Memphis, TN 38163 USA
[3] Univ Tennessee, Hlth Sci Ctr, Div Cardiol, 1325 Eastmoreland Ave Suite 460, Memphis, TN 38104 USA
[4] St Francis Cardiol Associates, 6005 Pk Ave,Suite500 B, Memphis, TN 38119 USA
来源：
FUTURE CARDIOLOGY | 2018年 / 14卷 / 01期
关键词：
apixaban; atrial fibrillation; betrixaban; dabigatran; edoxaban; review; rivaroxaban; venous thromboembolism;
D O I：
10.2217/fca-2017-0045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Following publication of our review article 4 years ago, there has been an uptake in the use of nonvitamin K oral antagonists, also known as direct oral anticoagulants. The most recent Xa inhibitors to receive approval are edoxaban, which has been approved for use in both atrial fibrillation and venous thromboembolism prevention and betrixaban, which has been approved in the USA for extended thromboprophylaxis in the medically ill population. Additional analyses of certain types of atrial fibrillation patients have now become available. Ongoing prescriber vigilance is recommended as additional information continues to emerge with this class of medications. The purpose of this paper is to provide an update on the use of the direct oral anticoagulant agents for the prevention and treatment of thromboembolism.
引用
收藏
页码：89 / 99
页数：11
相关论文
共 50 条
  • [21] Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
    Martin, Karlyn A.
    Beyer-Westendorf, Jan
    Davidson, Bruce L.
    Huisman, Menno V.
    Sandset, Per Morten
    Moll, Stephan
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (08) : 1874 - 1882
  • [22] Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
    Gomez-Outes, Antonio
    Isabel Terleira-Fernandez, Ana
    Lecumberri, Ramon
    Luisa Suarez-Gea, M.
    Vargas-Castrillon, Emilio
    THROMBOSIS RESEARCH, 2014, 134 (04) : 774 - 782
  • [23] Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants
    Deftereos, Spyridon
    Hatzis, Georgios
    Kossyvakis, Charalambos
    Bouras, Georgios
    Panagopoulou, Vasiliki
    Kaoukis, Andreas
    Tousoulis, Dimitris
    Stefanadis, Christodoulos
    CURRENT CLINICAL PHARMACOLOGY, 2012, 7 (03): : 175 - 194
  • [24] Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
    Qureshi, Waqas
    Ali, Zeeshan
    Amjad, Waseem
    Alirhayim, Zaid
    Farooq, Hina
    Qadir, Shayan
    Khalid, Fatima
    Al-Mallah, Mouaz H.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2016, 3
  • [25] Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism
    Bertoletti, Laurent
    Ollier, Edouard
    Duvillard, Cecile
    Delavenne, Xavier
    Beyens, Marie-Noelle
    De Magalhaes, Elodie
    Bellet, Florelle
    Basset, Thierry
    Mismetti, Patrick
    Laporte, Silvy
    PHARMACOLOGICAL RESEARCH, 2017, 118 : 33 - 42
  • [26] Direct oral anticoagulants. Dental update
    Dinkova, Atanaska
    Daskalov, Hristo
    Drangov, Martin
    Dandarov, Yavor
    JOURNAL OF IMAB, 2022, 22 : 17 - 20
  • [27] Persistence to direct oral anticoagulants for acute venous thromboembolism
    Dronkers, Charlotte E. A.
    Lijfering, Willem M.
    Teichert, Martina
    van der Meer, Felix J. M.
    Klok, Frederikus A.
    Cannegieter, Suzanne C.
    Huisman, Menno V.
    THROMBOSIS RESEARCH, 2018, 167 : 135 - 141
  • [28] The use of direct oral anticoagulants in inherited thrombophilia
    Jessica W. Skelley
    C. Whitney White
    Angela R. Thomason
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 24 - 30
  • [29] The use of direct oral anticoagulants in inherited thrombophilia
    Skelley, Jessica W.
    White, C. Whitney
    Thomason, Angela R.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (01) : 24 - 30
  • [30] All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism
    Roetker, Nicholas S.
    Lutsey, Pamela L.
    Zakai, Neil A.
    Alonso, Alvaro
    Adam, Terrence J.
    MacLehose, Richard F.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (09) : 1637 - 1645
12345